首页>投融资

PhoreMost

B轮

PhoreMost Ltd is a biopharmaceutical company developing therapeutics for cancer and other difficult diseases. The company is managed by the founder of the University of Cambridge spin-off Horizon Discovery.In March 2021, XtalPi invested in the Series B financing of PhoreMost Ltd.In March 2021, PhoreMost Ltd announced it has completed an oversubscribed £33m ($46m) Series B investment round,.In March 2021, o2h Ventures invested into PhoreMost Ltd.In May 2018, the company completed a GBP 11 million ($14.92 million) series-A investment round.In April 2015, the company raised GBP 2.5 million ($3.26 million) in a seed-funding

http://www.phoremost.com/

470228

基本信息

公司全称

PhoreMost Ltd
类型

新型药物研发商
产业领域

医药研发/制造、化学&生物药
公司人数

15人以下
地址

Unit 7 The Works Unity Campus Pampisford CAMBRIDGE CB22 3FT; GB; Telephone: +441223856740;
联系电话

4401223437110
邮箱

info@phoremost.com
成立时间

2010-08-10

投融资

2024-09-16

B轮

1200万美元

Parkwalk Advisors

Astellas Venture Management

BGF
2021-03-23

B轮

4600万美元

BGF

Morningside Venture Partners

Parkwalk Advisors

O2h Ventures

Trend Investment Group

Astellas Venture Management

晶泰科技
2019-06-24

B轮

未透露

未透露
2018-05-15

A轮

1500万美元

Parkwalk Advisors

Amadeus Capital Partners

University of Cambridge Seed Funds
2015-03-11

种子轮

380万美元

Amadeus Capital Partners

Parkwalk Advisors
加载更多

PhoreMost

基本信息

投融资

相关投融资企业